Compare IMXI & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMXI | SLP |
|---|---|---|
| Founded | 1994 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | EDP Services |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 460.6M | 418.4M |
| IPO Year | N/A | 1997 |
| Metric | IMXI | SLP |
|---|---|---|
| Price | $15.47 | $20.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $16.67 | ★ $28.00 |
| AVG Volume (30 Days) | 198.7K | ★ 325.3K |
| Earning Date | 02-25-2026 | 01-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $625,123,000.00 | $78,676,000.00 |
| Revenue This Year | N/A | $2.64 |
| Revenue Next Year | $0.95 | $6.01 |
| P/E Ratio | $12.01 | ★ N/A |
| Revenue Growth | N/A | ★ 5.70 |
| 52 Week Low | $8.58 | $12.39 |
| 52 Week High | $19.86 | $37.67 |
| Indicator | IMXI | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 57.18 | 65.11 |
| Support Level | $15.40 | $19.50 |
| Resistance Level | $15.53 | $20.60 |
| Average True Range (ATR) | 0.06 | 1.09 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 68.18 | 98.50 |
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.